ARTICLE | Company News
BioInvent, Immusol deal
April 10, 2006 7:00 AM UTC
The companies partnered to develop and commercialize a preclinical antibody to treat age-related macular degeneration (AMD). BINV will provide the human antibody, and Immusol will provide the undisclo...